Mechanistic Distinctions Between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy With Gemcitabine

Cancer Research - United States
doi 10.1158/0008-5472.can-17-3932
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search